Harmony Biosciences Holdings

HRMY · Moat type: REGULIERUNG

MoatScore

6/10

Fair Value

74 USD

Margin of Safety

+52.0 %

Rating

BEOBACHTEN

Harmony Biosciences Holdings develops and markets prescription medications for patients with central nervous system (CNS)-related diseases, particularly sleep disorders such as narcolepsy, and generates revenues primarily through the US pharmaceutical market.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.